Multi-ear system to enhance monocot plant yield

Patent metadata

Field	Value
Publication number	US-10772274-B2
Application number	US-201615745224-A
Country	US
Kind code	B2
Filing date	Jul 15, 2016
Priority date	Jul 16, 2015
Publication date	Sep 15, 2020
Grant date	Sep 15, 2020

Abstract

Provided are methods for increasing the yield of a monocot plant through treatment of the plant with a plant growth regulator. In certain embodiments, maize plants produce multiple ears and an increased number of kernels. In certain embodiments, reduced height of the plant allows for more efficient self-pollination.

First claim

What is claimed is:

1. A method of treating a maize plant with a gibberellic acid-inhibitor (GA-inhibitor), the method comprising:
administering the GA-inhibitor to the plant by contacting the plant with the GA-inhibitor prior to the formation of a visible reproductive structure, wherein the treatment results in at least one tiller being produced on the treated plant;
separating at least one tiller from the main stalk of the treated plant and replanting the tiller separately,
wherein the treatment increases seed yield of the maize plant.

2. The method of claim 1 , wherein the GA-inhibitor is administered by contacting the roots of the plant.

3. The method of claim 1 , wherein the treatment reduces plant height.

4. The method of claim 1 , wherein the plant is an inbred V1 to V13 stage plant or a hybrid V1 to V15 stage plant.

5. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor to the plant from the V1 stage up to about 10 days before the last tassel branch has emerged from the whorl (VT) [VT—10 days] and 2-3 days before silk emergence.

6. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor from about 5 days post germination to about 40 days post germination.

7. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor at the V1, V2, V3, V4, or V5 stage and/or from about 5 days post germination to about 20 days post germination.

8. The method of claim 7 , wherein the treatment increases tassel number.

9. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor at the V6, V7, V8, or V9 stage and/or from about 21 days post germination to about 35 days post germination.

10. The method of claim 9 , wherein the plant is a maize plant and wherein the treatment induces co-dominant ears on the main stem.

11. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor at the V10, V11, or V12 stage and/or from about 35 days post germination to about 40 days post germination.

12. The method of claim 11 , wherein the plant is a maize plant and wherein the treatment compresses the nodes above the primary ear.

13. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor: i) first at the V1, V2, V3, V4, or V5 stage and/or from about 5 days post germination to about 20 days post germination and then ii) again at the V6, V7, V8, or V9 stage and/or from about 21 days post germination to about 35 days post germination.

14. The method of claim 13 , wherein the treatment further comprises at least one administration of the GA-inhibitor at the V10, V11, or V12 stage and/or from about 35 days post germination to about 40 days post germination.

15. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor: i) first at the V1, V2, V3, V4 or V5 stage and/or from about 5 days post germination to about 20 days post germination and then ii) again at the V10, V11, or V12 stage and/or from about 35 days post germination to about 40 days post germination.

16. The method of claim 1 , wherein the treatment comprises at least one administration of the GA-inhibitor: i) first at the V6, V7, V8, or V9 stage and/or from about 21 days post germination to about 35 days post germination and then ii) again at the V10, V11, or V12 stage and/or from about 35 days post germination to about 40 days post germination.

17. The method of claim 1 , wherein the GA-inhibitor is a triazole.

18. The method of claim 17 , wherein the triazole is selected from the group consisting of paclobutrazol, uniconazole, and flurprimidol.

19. The method of claim 1 , wherein the GA-inhibitor is administered at a rate of at least 1.0 mg/plant.

20. The method of claim 1 , wherein the GA-inhibitor is administered at a rate of from about 1.0 mg/plant to about 75 mg/plant.

21. The method of claim 1 , wherein the treatment comprises administration of the GA-inhibitor at the V1, V2, V3, V4, or V5 stage and/or from about 5 days post germination to about 20 days post germination and the GA-inhibitor is administered at a rate of from about 1.0 mg/plant to about 8.0 mg/plant.

22. The method of claim 1 , wherein the treatment comprises administration of the GA-inhibitor at the V6, V7, V8, V9, V10, V11, or V12 stage and/or from about 21 days post germination to about 40 days post germination and the GA-inhibitor is administered at a rate of from about 8.0 mg/plant to about 75 mg/plant.

23. The method of claim 1 , wherein the monocot plant is a maize plant and the treatment results in 2, 3, 4, 5, 6, or 7 tillers on the treated plant.

24. The method of claim 23 , wherein the tillers have delayed feminization and increased maleness.

25. The method of claim 1 , wherein treatment with the GA-inhibitor increases pollen shed duration.

26. The method of claim 1 , wherein the GA-inhibitor treated plant produces at least 1, 2, 3, 4, or 5, or more tillers than a control plant which was not contacted with the GA-inhibitor.

27. The method of claim 1 , wherein one or more of the replanted tillers is treated with a GA-inhibitor.

28. The method of claim 1 , wherein the replanted tillers produce more kernels in comparison to control tillers that are not separated from the main stalk.

29. The method of claim 1 , wherein the monocot plant is a maize plant and the GA-inhibitor-treatment results in at least about 600 kernels from the treated plant.

30. The method of claim 1 , further comprising harvesting the seed of a maize plant that produced at least about 250 kernels.

31. The method of claim 30 , further comprising genotyping a harvested seed or a population of harvested seeds.

32. The method of claim 30 , further comprising using a harvested seed or a population of harvested seeds in a breeding program.

33. The method of claim 1 , wherein the treated plant is grown under controlled conditions.

34. The method of claim 33 , wherein the treated plant is grown in a green house.

35. The method of claim 1 , wherein the treated plant is grown in an open field.

36. The method of claim 1 , wherein a population of commercially planted plants is treated and wherein said treatment increases yield in comparison to a population of untreated control plants.

37. The method of claim 1 , wherein the GA-inhibitor is administered at a rate of from about 1.0 mg/plant to about 50 mg/plant.

38. The method of claim 1 , wherein the GA-inhibitor is administered at a rate of from about 1.0 mg/plant to about 32 mg/plant.

39. The method of claim 1 , wherein the treatment comprises administration of the GA-inhibitor at the V1, V2, V3, V4, or V5 stage and/or from about 5 days post germination to about 20 days post germination and the GA-inhibitor is administered at a rate of from about 1.5 mg/plant to about 5.0 mg/plant.

40. The method of claim 1 , wherein the treatment comprises administration of the GA-inhibitor at the V6, V7, V8, V9, V10, V11, or V12 stage and/or from about 21 days post germination to about 40 days post g

Assignees

• Monsanto Technology Llc

Inventors

• Ovadya Daniel
• Savidge Beth
• Smith Kyle
• Val Dale

Classifications

• A01H1/08

  Methods for producing changes in chromosome number · CPC title

• C12N15/8261

  with agronomic (input) traits, e.g. crop yield · CPC title

• A01N45/00

  Biocides, pest repellants or attractants, or plant growth regulators, containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring (halogenated hydrocarbons A01N29/08; condensed with heterocyclic rings A01N43/00) · CPC title

• A01N43/653

  1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles · CPC title

• A01N43/12

  condensed with a carbocyclic ring · CPC title